BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kommineni N, Pandi P, Chella N, Domb AJ, Khan W. Antibody drug conjugates: Development, characterization, and regulatory considerations. Polym Adv Technol 2020;31:1177-93. [DOI: 10.1002/pat.4789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Matsuda Y, Mendelsohn BA. An overview of process development for antibody-drug conjugates produced by chemical conjugation technology. Expert Opin Biol Ther 2021;21:963-75. [PMID: 33141625 DOI: 10.1080/14712598.2021.1846714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Shan X, Gong X, Li J, Wen J, Li Y, Zhang Z. Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.025] [Reference Citation Analysis]